GO:0060928 atrioventricular node cell development: Origin, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060928 describes the progression of an atrioventricular (AV) node cell from its formation to its mature state, a specialized biological process within cardiac conduction system development.
• The AV node is a key component of the cardiac conduction system, responsible for delaying electrical impulses between atria and ventricles, and its development is governed by a distinct genetic program.
• Key transcription factors such as GATA6 and members of the T-box family are critical for AV node cell development and function.
• Hedgehog signaling controls sinoatrial node development and atrioventricular cushion formation, indirectly influencing AV node cell development.
• Disruption of AV node cell development can lead to congenital heart block, arrhythmias, and other conduction disorders.
• Modern research employs CRISPR knockout, knock-in, and overexpression models, alongside transcriptomic and imaging methods, to dissect AV node cell development.
Description
The atrioventricular (AV) node is a specialized cluster of cells within the cardiac conduction system that orchestrates the sequential contraction of the heart by delaying electrical impulses between the atria and ventricles. The development of AV node cells, defined by the Gene Ontology term GO:0060928, encompasses the cellular and molecular events that transform progenitor cells into mature, functional AV node cells. Understanding this process is fundamental to cardiac developmental biology and has direct clinical implications for arrhythmias and conduction disorders. Research over the past decades has elucidated the anatomical origin, genetic regulation, and signaling pathways that govern AV node cell development. The AV node arises from the embryonic heart tube, specifically from the atrioventricular canal region, and its development is marked by the expression of unique transcription factors and ion channels that confer its distinctive electrophysiological properties. Studies in animal models have shown that perturbations in these developmental programs can lead to congenital heart block and other conduction abnormalities. Moreover, the AV node's role in cardiac function makes it a target for regenerative medicine and pharmacological interventions. This article synthesizes current knowledge on AV node cell development, highlighting key genes, regulatory mechanisms, and research methodologies, with a focus on CRISPR-based approaches for functional genomics.
atrioventricular node cell development At A Glance
| GO ID | GO:0060928 |
|---|---|
| GO term | atrioventricular node cell development |
| Ontology | biological_process |
| Synonym | AV node cell development |
| Definition | The process whose specific outcome is the progression of an atrioventricular (AV) node cell over time, from its formation to the mature state. |
| Major function | Formation and maturation of AV node cells, which are essential for delaying electrical impulses in the heart. |
| Related process | Cardiac conduction system development, cell differentiation, heart development. |
| Key regulators | GATA6, TBX3, TBX5, SHH, and other transcription factors and signaling pathways. |
What Is GO:0060928?
GO:0060928, atrioventricular node cell development, is the biological process by which an atrioventricular node cell progresses from its initial formation to a mature, functional state. This includes the specification of progenitor cells, their differentiation into specialized conduction cells, and the acquisition of mature electrophysiological and morphological characteristics. The process is part of the broader development of the cardiac conduction system and is essential for normal heart rhythm.
Why Is atrioventricular node cell development Important in Cell Biology?
AV node cell development is critical for establishing the correct sequence of cardiac contractions. Dysregulation of this process can result in congenital heart block, arrhythmias, and other conduction defects, making it a significant area of study for both developmental biologists and clinicians.
• AV node cell development ensures proper electrical insulation and delay between atria and ventricles, preventing simultaneous contraction.
• Defects in AV node development are linked to congenital heart block and arrhythmias.
• Understanding AV node development aids in the design of biological pacemakers and regenerative therapies.
• Key transcription factors like GATA6 and TBX3 are essential for AV node cell fate and function.
• Hedgehog signaling influences AV cushion formation, which is crucial for AV node development.
• AV node cell development is a model for studying cell fate specification and electrophysiological maturation.
• Research on AV node development can inform pharmacological targeting of conduction disorders.
• CRISPR-based models enable precise dissection of gene function in AV node development.
What Happens During atrioventricular node cell development?
Specification of AV node progenitors
In simple terms: Early in heart development, certain cells are told to become AV node cells.
During embryogenesis, progenitor cells in the atrioventricular canal region are specified to adopt an AV node fate. This specification is driven by a combination of transcription factors and signaling molecules, including GATA6 and T-box proteins. The AV canal is characterized by the expression of TBX3, which suppresses working myocardial genes and promotes conduction cell identity.
Formation of the AV node primordium
In simple terms: The specified cells cluster together to form the initial AV node structure.
The AV node primordium forms as a distinct anatomical structure within the AV canal. It is marked by the expression of specific markers such as HCN4 and connexin proteins. Hedgehog signaling from the endocardium contributes to the formation of the AV cushions, which are essential for AV node development.
Differentiation and maturation of AV node cells
In simple terms: The AV node cells mature to become fully functional, with unique electrical properties.
AV node cells undergo differentiation to acquire their characteristic slow conduction and automaticity. This involves the expression of ion channels such as HCN4 and the downregulation of fast-conducting gap junction proteins like connexin 43. The maturation process is regulated by transcription factors including GATA6, which is required for AV node function.
Integration into the cardiac conduction system
In simple terms: The AV node connects with other parts of the heart's electrical system.
The mature AV node integrates with the sinoatrial node and the His-Purkinje system to coordinate heart rhythm. This integration involves the formation of specialized conduction pathways and the establishment of electrical coupling. The inferior extensions of the AV node, as described by Anderson et al., play a role in this integration.
Key Genes Involved in GO:0060928 atrioventricular node cell development
The following genes are key regulators of atrioventricular node cell development, as identified in published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GATA6 | Transcription factor essential for AV node development and function | Knockout leads to AV conduction defects; studied in mouse models |
| TBX3 | Represses working myocardial genes, promotes conduction cell fate | Key marker of AV node; knockout causes conduction abnormalities |
| TBX5 | Transcription factor involved in cardiac conduction system development | Mutations linked to Holt-Oram syndrome with conduction defects |
| SHH | Signaling molecule controlling AV cushion formation | Hedgehog pathway manipulation affects AV node development |
| HCN4 | Ion channel responsible for pacemaker current If | Marker of AV node cells; essential for automaticity |
| CX40 (GJA5) | Gap junction protein for electrical coupling | Expressed in AV node; knockout affects conduction |
| CX43 (GJA1) | Gap junction protein in working myocardium | Downregulated in AV node; important for insulation |
| NKX2-5 | Transcription factor in heart development | Mutations associated with AV block |
| PITX2 | Transcription factor in left-right asymmetry | Involved in AV node development and atrial fibrillation |
| ISL1 | Transcription factor in cardiac progenitors | Marks AV node progenitors; important for development |
| BMP2 | Signaling molecule in AV canal | Regulates AV node formation |
| NOTCH1 | Signaling receptor in endocardium | Involved in AV cushion formation |
| SOX2 | Transcription factor in progenitors | May play a role in AV node development |
| MEF2C | Transcription factor in cardiac development | Regulates AV node gene expression |
| HAND2 | Transcription factor in heart development | Involved in AV node development |
| TBX2 | Transcription factor repressing conduction genes | Knockout leads to ectopic AV node formation |
| GATA4 | Transcription factor in heart development | Cooperates with GATA6 in AV node development |
| NPPA | Natruretic peptide precursor | Marker of working myocardium; absent in AV node |
How Is atrioventricular node cell development Regulated?
The development of the AV node is regulated by a complex network of transcription factors and signaling pathways. GATA6, for example, is a key regulator that controls genes involved in AV node function and development. Hedgehog signaling, through SHH, regulates AV cushion formation, which is a prerequisite for AV node development. Additionally, T-box transcription factors such as TBX3 and TBX2 act antagonistically to define the AV node boundary. Postnatal maturation of the conduction system involves further transcriptional changes, as revealed by single-cell transcriptomics.
atrioventricular node cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATA6 | Congenital heart block, AV conduction defects | Knockout mouse, patient-derived iPSCs |
| TBX5 | Holt-Oram syndrome, AV block | Knockout mouse, zebrafish |
| SHH | AV cushion defects, conduction abnormalities | Conditional knockout mouse |
| HCN4 | Sinus node dysfunction, AV block | Knock-in mouse, iPSC-derived cardiomyocytes |
| NKX2-5 | Congenital heart disease, AV block | Knockout mouse, human genetics |
Congenital Heart Block
Congenital heart block is a rare but serious condition characterized by failure of electrical impulses to conduct from atria to ventricles. It can result from developmental defects in the AV node. Mutations in genes such as GATA6 have been associated with AV block. Autoimmune-mediated damage to the AV node in fetuses of mothers with anti-Ro/SSA antibodies is another cause, but developmental defects are also significant.
Arrhythmias and Conduction Disorders
Abnormalities in AV node cell development can lead to arrhythmias such as atrioventricular nodal reentrant tachycardia (AVNRT) and other conduction disorders. The inferior extensions of the AV node have been implicated in AVNRT. Understanding the developmental origins of these structures may provide insights into arrhythmia mechanisms.
Holt-Oram Syndrome
Holt-Oram syndrome, caused by mutations in TBX5, is characterized by upper limb abnormalities and congenital heart defects, including conduction system anomalies. TBX5 is critical for AV node development, and its dysfunction can lead to AV block.
From atrioventricular node cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate AV node cell fate? | CRISPR knockout in mouse embryonic stem cells or iPSCs |
| What is the effect of a point mutation in gene Y on AV node function? | CRISPR point mutation knock-in in mouse or human iPSCs |
| How does overexpression of gene Z affect AV node development? | CRISPR-mediated overexpression (e.g., CRISPRa) in cardiomyocytes |
| Where is protein W localized in AV node cells? | Tagged knock-in (e.g., GFP) in mouse or human cells |
| What are the transcriptomic changes during AV node maturation? | RNA-seq of sorted AV node cells from knockout/overexpression models |
| Can we screen for novel regulators of AV node development? | CRISPR library screening in iPSC-derived cardiomyocytes |
How to Study the atrioventricular node cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify differentially expressed genes during AV node development |
| Single-cell RNA-seq | Transcriptomes of individual cells | Uncover cellular heterogeneity in AV node |
| Patch-clamp | Ion channel activity and action potentials | Assess electrophysiological maturation of AV node cells |
| MEA | Extracellular field potentials | Measure conduction properties in AV node cell cultures |
| Immunofluorescence | Protein localization and expression | Validate markers like HCN4, TBX3 in AV node tissue |
| CRISPR knockout | Gene function loss | Determine if a gene is required for AV node development |
| CRISPR knock-in | Introduction of specific mutations or tags | Model disease mutations or track proteins |
| ATAC-seq | Chromatin accessibility | Identify regulatory regions active in AV node cells |
Transcriptomic Profiling
RNA sequencing (RNA-seq) of AV node cells at different developmental stages can reveal gene expression dynamics. Single-cell RNA-seq has been used to uncover heterogeneity in the postnatal cardiac conduction system. This method identifies novel markers and regulatory pathways.
Electrophysiological Recordings
Patch-clamp and multielectrode array (MEA) recordings measure the electrical properties of AV node cells, such as action potential duration and conduction velocity. These techniques are essential to confirm functional maturation in vitro.
Imaging and Lineage Tracing
Confocal and light-sheet microscopy of fluorescently labeled AV node cells (e.g., HCN4-GFP) allow visualization of their development and integration. Lineage tracing using Cre-lox systems can determine the origin of AV node cells.
CRISPR-Based Functional Genomics
CRISPR knockout, knock-in, and overexpression models enable precise manipulation of candidate genes. These approaches can be combined with transcriptomics and electrophysiology to establish causality.
How CRISPR Can Be Used to Study GO:0060928 atrioventricular node cell development
Knockout
CRISPR knockout (KO) is used to delete candidate genes in model systems such as mouse embryos or human induced pluripotent stem cells (iPSCs). For example, GATA6 knockout mice exhibit AV conduction defects, confirming its essential role. KO studies help establish causality between gene function and AV node development.
Point Mutation
CRISPR point mutation knock-in introduces specific nucleotide changes to model human disease variants. For instance, mutations in TBX5 found in Holt-Oram syndrome can be recapitulated in iPSCs to study their impact on AV node development. This approach provides insights into genotype-phenotype relationships.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows visualization and purification of AV node cells. Tagging endogenous HCN4 with a fluorescent protein enables live imaging of AV node development. Knock-in can also be used to overexpress genes under endogenous regulatory control.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression constructs can drive ectopic expression of candidate genes. Overexpressing TBX3 in working myocardium can induce conduction cell-like properties, highlighting its role in AV node development. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports atrioventricular node cell development Research
Researchers studying atrioventricular node cell development-related genes often need to determine whether a candidate gene is causally involved in the process, and to dissect its precise function using robust genetic models. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for atrioventricular node cell development research.
Frequently Asked Questions About atrioventricular node cell development
What is atrioventricular node cell development?
Atrioventricular node cell development (GO:0060928) is the biological process by which AV node cells progress from formation to maturity, acquiring specialized electrophysiological properties.
What genes are involved in atrioventricular node cell development?
Key genes include GATA6, TBX3, TBX5, SHH, HCN4, and NKX2-5, among others.
How does the AV node develop?
The AV node develops from progenitor cells in the atrioventricular canal, guided by transcription factors and signaling pathways such as Hedgehog and Notch.
What diseases are associated with abnormal AV node development?
Congenital heart block, arrhythmias like AVNRT, and Holt-Oram syndrome are linked to defects in AV node development.
What is the role of GATA6 in AV node development?
GATA6 is a transcription factor essential for AV node development and function; its knockout leads to AV conduction defects.
How is Hedgehog signaling involved in AV node development?
Hedgehog signaling controls atrioventricular cushion formation, which is necessary for proper AV node development.
What research methods are used to study AV node cell development?
Methods include RNA-seq, single-cell RNA-seq, patch-clamp, imaging, and CRISPR-based functional genomics.
Can CRISPR be used to study AV node development?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise manipulation of genes to study their roles in AV node development.
What is the clinical significance of AV node cell development?
Understanding AV node development can inform treatments for congenital heart block and arrhythmias, and aid in regenerative strategies.
What are the key transcription factors in AV node development?
GATA6, TBX3, TBX5, and NKX2-5 are critical transcription factors regulating AV node cell fate and function.
Conclusion
Atrioventricular node cell development (GO:0060928) is a finely orchestrated biological process essential for normal cardiac function. Advances in genetic and genomic technologies, particularly CRISPR-based models, have illuminated the roles of key transcription factors and signaling pathways. Continued research will enhance our understanding of AV node biology and provide new avenues for treating conduction disorders.
References
- 2. Anderson RH et al.. 2009. The anatomy of the cardiac conduction system.. Clin Anat 22(1):99-113 PMID: 18773472
- 3. Zhang C et al.. 2021. Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation.. Open Biol 11(6):210020 PMID: 34062094
- 4. Anderson RH et al.. 2025. The Anatomy of the Atrioventricular Node.. J Cardiovasc Dev Dis 12(7) PMID: 40710771
- 5. Bakker ML et al.. 2010. The atrioventricular node: origin, development, and genetic program.. Trends Cardiovasc Med 20(5):164-71 PMID: 21742272
- 6. Anderson RH et al.. 2021. Inferior Extensions of the Atrioventricular Node.. Arrhythm Electrophysiol Rev 10(4):262-272 PMID: 35106179
- 7. Liu F et al.. 2015. GATA-Binding Factor 6 Contributes to Atrioventricular Node Development and Function.. Circ Cardiovasc Genet 8(2):284-93 PMID: 25613430
- 8. Oh Y et al.. 2024. Transcriptional regulation of the postnatal cardiac conduction system heterogeneity.. Nat Commun 15(1):6550 PMID: 39095365
